Concepedia

Lomeguatrib, a Potent Inhibitor of <i>O</i>6-Alkylguanine-DNA-Alkyltransferase: Phase I Safety, Pharmacodynamic, and Pharmacokinetic Trial and Evaluation in Combination with Temozolomide in Patients with Advanced Solid Tumors

Malcolm Ranson, Mark R. Middleton, John Bridgewater, Siow Ming Lee, Martin D. Dawson, Debra Jowle, Gavin Halbert, S. Waller, Helen E. McGrath, Lindsey Gumbrell,

Clinical Cancer Research · 2006 · 142 citations · 26 references

DOIFull text

Open access

Abstract

This first administration of lomeguatrib to man successfully established an oral ADD of lomeguatrib and identified a combination regimen with temozolomide suitable for future clinical evaluation.

References

26

Depletion of mammalian O6-alkylguanine-DNA alkyltransferase activity by O6-benzylguanine provides a means to evaluate the role of this protein in protection against carcinogenic and therapeutic alkylating agents.

M. Eileen Dolan, Robert C. Moschel, Anthony E. Pegg · Proceedings of the National Academy of Sciences · 1990 · 459 citations · Full text

, , +13

Phase II Study of First-Line Chemotherapy With Temozolomide in Recurrent Oligodendroglial Tumors: The European Organization for Research and Treatment of Cancer Brain Tumor Group Study 26971

Martin J. van den Bent, Alba A. Brandes, Johan Menten et al. · Journal of Clinical Oncology · 2003 · 295 citations

Phase I Trial of Temozolomide Plus <i>O</i><sup>6</sup>-Benzylguanine for Patients With Recurrent or Progressive Malignant Glioma

Jennifer A. Quinn, Annick Desjardins, Jon Weingart et al. · Journal of Clinical Oncology · 2005 · 291 citations · Full text

O6-benzylguanine and its role in chemotherapy.

M. Eileen Dolan, Anthony E. Pegg · PubMed · 1997 · 216 citations

, , +11

Phase II Trial of Carmustine Plus O<sup>6</sup>-Benzylguanine for Patients With Nitrosourea-Resistant Recurrent or Progressive Malignant Glioma

Jennifer A. Quinn, James M. Pluda, M. Eileen Dolan et al. · Journal of Clinical Oncology · 2002 · 194 citations